Butirex C4

Name: Butirex® C4.
Ingredients: 1 kg contains:

– Sodium salt of butyric acid (E470) – 540 g;

– Colloidal silicon dioxide (E551b) – 460 g

Does not contain GMOs.
Pharmaceutical form:  White powder with a specirfic ordor.
Pharmacological properties:  Improved digestion, due to stimulation of pancreatic enzymes, in particular, amylase. Inhibition of pathogenic microflora (E.coli, Salmonella, Clostridium spp. ).
Clinical properties: 
Groups of animals: Pigs, ruminants, farm poultry, dogs, cats, rabbits.
Indications for use: Improvement of digestion in farm animals and poultry.
Contraindications: Not identified.
Special warnings: strict compliance with the application instructions.
Use during pregnancy and lactation: No adverse side effects detected.
Interaction with other products or other forms of interaction: Compatible with other feed and medicine ingredients.
Dosing and routes of administration for animals of different age Mix with food at a rate of 1000 kg of feed:
– piglets – 3-5 kg;

– fattening pigs – 1-2 kg;

– sows – 2-3 kg

Ruminants – 2-4 kg

Farm poultry:

– broilers, layer chicken, parent stock of broilers – 1 -2 kg

Dogs, cats – 1-2 kg.
Rabbits – 2-4 kg
Overdoses: Not detected.
Special warnings for staff: Not detected.
Pharmaceutical features:
Shelf life: 24 months.
Special precautions during storage: Store in tightly sealed original packaging in a dry and dark place at a temperature of 5-25 °С.
Nature and composition of original packaging: Bags 25 kg, pallets1000 kg,
Special precautions for handling unused product or its residues: Not detected.
Name and location of the registration holder and manufacturer: Novation 2002 S.L., Ctra. Aguilar de Montuenga, Km.2, Arcos de Jalón (Soria), Spain